Before visiting mom in-person on Mother’s Day, ask yourself these key questions
- Many are asking Google the question this morning “is it safe to visit my mom on Mother’s Day?” “Can I send or give her a card?”
- As the coronavirus pandemic continues, this Mother’s Day will be much different?
There are a few basic questions your family has to address before taking any kind of risk
Before visiting in-person, you must ask yourself:
- Are you or anyone in your family in a “high-risk” group? (e.g. chronic disease or age 65 and over)
- Is anyone in your family in frequent contact with the public?
- Are you in an urban area with a lot of cases?
- Can your visit take place six feet apart, preferably outdoors?
If you answered yes…
- it is wise to forgo any thought of an in-person visit, especially if mom is older and/or has a chronic disease.You can read more about how coronavirus spreads at the Centers for Disease Control and Prevention here.
Also read how to clean and disinfect your home here.
The CDC says while the virus can survive a short time on surfaces, it’s unlikely to be spread that way:
- But, what about your mail and packages? According to the World Health Organization, the COVID-19 virus can survive for up to 72 hours on plastic and less than 24 hours on cardboard. Although the virus can survive for a short period on some surfaces, the CDC (Centers of Disease Control) says, it is unlikely to be spread from domestic or international mail, products or packaging.If you’re worried about the coronavirus, the CDC (Centers of Disease Control) offers the following tips for handling packages and mail.
- Limit in person contact if possible.
- Accept deliveries without in-person contact whenever possible.
- Stay at least 6 feet away from the delivery person.
- After collecting mail or accepting deliveries, wash your hands with soap and water for at least 20 seconds.
- Place your mail or package aside in the corner or in a room for 24 hours before opening.
- Use a hand sanitizer.
Coronavirus Treatment: Arthritis Drug Appears Promising With 90% Survival Rate And Reduced Respiratory Symptoms
- Treatment options for critically ill COVID-19 patients treated outside ICU s- need of the hour
- A recent study demonstrated that arthritis drug anakinra appeared promising
- The U.S.FDA approved arthritis drug found to be safe and effective in treating ARDS
Rheumatoid Arthritis drug anakinra has been reported to be promising in treating acute respiratory distress syndrome and hyper-inflammation in COVID-19 patients reported a new study. It is the first-ever study to demonstrate the safety and efficacy of an arthritis drug in treating COVID-19.
The study included 29 patients who received standard care of non-invasive ventilation, hydroxy chloroquine, and lopinavir/ritonavir alongside the daily high-dose intravenous infusion of the arthritis drug anakinra at 10 mg/kg body weight.
Although this is just an observational study, the findings revealed that the arthritis drug improved lung function in hospitalized COVID-19 patients.
Drug manufacturers are currently testing products including Actemra and Kevzara that treat inflammation than the coronavirus infection.
ARDS is said to be the main cause of death from COVID-19 and the estimated mortality rates range from 28% to 78%. But the number of patients who require ventilation could exceed the number of mechanical ventilators available.